©Zhiguo He
Clermont-Ferrand, France, Wednesday 1 October 2025 – Sepul Bio, an innovative business unit of Théa, dedicated to the advancement of RNA therapies for inherited retinal diseases, has
Kiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement
Théa and Link Biologics sign a new partnership
Théa and ProQR Therapeutics sign a new partnership
Théa and Olix Pharmaceuticals sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive licensing, co development and commercialization agreement